Beclomethasone Dipropionate

This page contains recent news articles, when available, and an overview of Beclomethasone Dipropionate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM ...  -  ‎Dec 28, 2009‎
Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment ... PR Newswire (press release)

Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the ...  -  ‎Dec 21, 2009‎
Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... CNNMoney.com (press release)

High-dose inhaled steroids for asthma may increase risk of fetal malformations  -  ‎Dec 19, 2009‎
...per day ICS (beclomethasone dipropionate-chlorofluorocarbone equivalent) versus 154 who took >1000 micrograms per day and 8734 who did not take ICS. ... news Stories

'�?�리�?�지�?성장용정' 약제 급여기준 신설  -  ‎Dec 21, 2009‎
Beclomethasone dipropionate 경구제(품명: �?�리�?�지�?성 장용정 5mg)�?� 급여기준�?� 신설�?�다. 보건복지가족부는 �?�같�?� 내용�?� �?�함한 약제급여 기준 개정안�?� 고시 ... 데일리팜

Soligenix Reports Third Quarter 2009 Financial Results  -  ‎Nov 13, 2009‎
Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... PR Newswire (press release)

Mometasone Furoate Triumphs Over Beclomethasone Dipropionate in Patients With ...  -  ‎Nov 10, 2009‎
..."When compared to beclomethasone dipropionate aerosol inhaler with hydrofluoroalkane propellant patients, mometasone furoate dry powder inhaler patients ... DG News

Enzon Offloads Specialty Arm to Sigma-Tau for up to $327M  -  ‎Nov 9, 2009‎
Currently, Sigma-Tau's orBec (oral beclomethasone dipropionate) is in Phase III testing for acute graft-vs.-host disease under a partnership with Solgenix ... BioWorld Online

Asthma Control Maintained in Children Switched to Once-Daily Mometasone ...  -  ‎Oct 22, 2009‎
...safely controls asthma in children switched from other corticosteroid therapies, such as fluticasone propionate or beclomethasone dipropionate, ... DG News

Bullish Technical Breakout Alert (OTC:SNGX.OB)  -  ‎Nov 11, 2009‎
Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... OfficialWire (press release)

Teva Pharmaceutical Industries Limited Q3 2009 Earnings Call Transcript  -  ‎Nov 3, 2009‎
The market share in NRx of 17% up from 13% in 2008 and I'm pleased to report that in October, we began Phase III trial of nasal beclomethasone dipropionate ... Seeking Alpha (blog)

Soligenix to Present at 8th Annual BIO Investor Forum  -  ‎Oct 27, 2009‎
Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... SunHerald.com (press release)

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.